Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Long Term Outcomes After Pull-through of Long Segment Hirschsprung Disease

NCT05461924 is registered in ClinicalTrials.gov with Weibing Tang as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05461924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Long Term Outcomes After Pull-through of Long Segment Hirschsprung Disease
Lead sponsor
Weibing Tang
Phase
Observational
Overall status
Unknown status
Start date
July 15, 2022
Completion date
August 20, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation, hirschsprung disease, long-segment, incontinence, long term adverse effects